PBD News and Press, Invesco Global Clean Energy From 11/25/20

The Ardour Global Alternative Energy Extra-Liquid Index (AGIXL) can provide investors with broad, globally-inclusive alternative energy exposure with the benefit of a liquidity screen. Alternative energy is positioned to become an increasingly important part of the global energy lands...

For elevating climate change issues across his administration, President-elect Joseph R. Biden Jr. has already undertaken steps to reduce planet-warming pollution and is seeking nominees who will embed climate policy not only in environmental agencies but in departments from Defense to T...

Protalix BioTherapeutics to Present at the H.C. Wainwright 6th Annual Israel Conference PR Newswire CARMIEL, Israel, Nov. 5, 2020 CARMIEL, Israel , Nov. 5, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical...

The U.S. officially pulled out of the Paris Climate Agreement yesterday after giving the required year's notice on Nov. 4, 2019.It makes the country the only one of 197 signatories to have withdrawn from the deal struck in 2015, and which Joe Biden has said would be revived if elected preside...

Protalix BioTherapeutics to Reschedule Third Quarter 2020 Financial Results and Business Update Call for Friday, October 30 PR Newswire CARMIEL, Israel, Oct. 29, 2020 CARMIEL, Israel , Oct. 29, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Am...

Protalix BioTherapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update Announced FDA acceptance of BLA filing of PRX-102 for the treatment of Fabry disease Top-line data from the BRIGHT study expected by end of first quarter, 2021 Management t...

Protalix BioTherapeutics to Participate in Virtual Investor KOL Roundtable Management and KOL scheduled to present on Wednesday, October 28 at 10:00 a.m. EDT PR Newswire CARMIEL, Israel, Oct. 26, 2020 CARMIEL, Israel , Oct. 26, 2020 /PRNewswire/ ...

Protalix BioTherapeutics to Hold Third Quarter 2020 Financial Results and Business Update Conference Call on October 29, 2020 Company to host conference call and webcast at 8:30 a.m. EDT PR Newswire CARMIEL, Israel, Oct. 22, 2020 CARMIEL, Israel , Oct. 22, ...

The transition toward a more sustainable energy system presents opportunities for investors, which have both patient capital and the sophistication to understand and underwrite the opportunity set. Renewable energy investment, a combination of public and private capital, exceeded $200...

CARMIEL, Israel , Sept. 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...